Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ali Kaplan

Showing results (91-100 of 149) with videos related to

Pageof 15
Sort By:
Clinical Genitourinary Cancer|September 1, 2015
Is Late Recurrence a Predictive Clinical Marker for Better Sunitinib Response in Metastatic Renal Cell Carcinoma Patients?Oktay Bozkurt, Ilhan Hacıbekiroglu, Muhammet Ali Kaplan, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|September 4, 2012
Weekly topotecan for recurrent small cell lung cancer - a retrospective Anatolian Medical Oncology Group studyMustafa Altinbas, Mehmet Emin Kalender, Basak Oven, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|January 22, 2013
Multiple primary malignant neoplasms: multi-center results from TurkeyN A Babacan, S Aksoy, B Cetin, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|March 25, 2014
Clinical characteristics, treatment and survival outcomes in malignant pleural mesothelioma: an institutional experience in TurkeyMehmet Kucukoner, Mehmet Ali Kaplan, Ali Inal, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|December 19, 2012
Gemcitabine plus paclitaxel as second-line chemotherapy in patients with advanced non-small cell lung cancerMeltem Baykara, Ugur Coskun, Veli Berk, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|October 27, 2012
Lack of any relationship between ABO and Rh blood groups and clinicopathological features in patients with gastrointestinal stromal tumors: Turkish Oncology GroupYüksel Ürün, Güngör Utkan, Şuayib Yalcin, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|June 28, 2013
Association of ABO blood group and risk of lung cancer in a multicenter study in TurkeyYuksel Urun, Gungor Utkan, Ayten Kayi Cangir, et al.
International Journal of Clinical Oncology|August 16, 2020
Comparison of three different chemotherapy regimens for concomitant chemoradiotherapy in locally advanced non-small cell lung cancerNadiye Akdeniz, Mehmet Küçüköner, Muhammet Ali Kaplan, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|December 2, 2019
Is eribulin treatment prognostic factor in patients with metastatic breast cancer treated with this drug? Retrospective analysis of a multicentre studyZeynep Oruc, Muhammet Ali Kaplan, Caglayan Geredeli, et al.
Pancreas|April 20, 2023
The Efficacy and Safety of Treatment Regimens Used in the First-Line Setting in Metastatic Pancreatic Cancer Patients: A Multicenter Real-Life StudyNadiye Akdeniz, Muhammet Ali Kaplan, Mevlüde İnanç, et al.
Pageof 15

Showing results (91-100 of 149) with videos related to

Sort By:
Pageof 15
Clinical Genitourinary Cancer|September 1, 2015
Is Late Recurrence a Predictive Clinical Marker for Better Sunitinib Response in Metastatic Renal Cell Carcinoma Patients?Oktay Bozkurt, Ilhan Hacıbekiroglu, Muhammet Ali Kaplan, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|September 4, 2012
Weekly topotecan for recurrent small cell lung cancer - a retrospective Anatolian Medical Oncology Group studyMustafa Altinbas, Mehmet Emin Kalender, Basak Oven, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|January 22, 2013
Multiple primary malignant neoplasms: multi-center results from TurkeyN A Babacan, S Aksoy, B Cetin, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|March 25, 2014
Clinical characteristics, treatment and survival outcomes in malignant pleural mesothelioma: an institutional experience in TurkeyMehmet Kucukoner, Mehmet Ali Kaplan, Ali Inal, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|December 19, 2012
Gemcitabine plus paclitaxel as second-line chemotherapy in patients with advanced non-small cell lung cancerMeltem Baykara, Ugur Coskun, Veli Berk, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|October 27, 2012
Lack of any relationship between ABO and Rh blood groups and clinicopathological features in patients with gastrointestinal stromal tumors: Turkish Oncology GroupYüksel Ürün, Güngör Utkan, Şuayib Yalcin, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|June 28, 2013
Association of ABO blood group and risk of lung cancer in a multicenter study in TurkeyYuksel Urun, Gungor Utkan, Ayten Kayi Cangir, et al.
International Journal of Clinical Oncology|August 16, 2020
Comparison of three different chemotherapy regimens for concomitant chemoradiotherapy in locally advanced non-small cell lung cancerNadiye Akdeniz, Mehmet Küçüköner, Muhammet Ali Kaplan, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|December 2, 2019
Is eribulin treatment prognostic factor in patients with metastatic breast cancer treated with this drug? Retrospective analysis of a multicentre studyZeynep Oruc, Muhammet Ali Kaplan, Caglayan Geredeli, et al.
Pancreas|April 20, 2023
The Efficacy and Safety of Treatment Regimens Used in the First-Line Setting in Metastatic Pancreatic Cancer Patients: A Multicenter Real-Life StudyNadiye Akdeniz, Muhammet Ali Kaplan, Mevlüde İnanç, et al.
Pageof 15